Clinical trial
Ropivacaine Versus Bupivacaine for Spinal Anaesthesia in Patients Undergoing…
NCT00358280 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00358280 |
|---|---|
| Title | Ropivacaine Versus Bupivacaine for Spinal Anaesthesia in Patients Undergoing Unilateral Lower Limb Surgery |
| Official title | A Randomised, Double-Blind, Multi-Centre, Parallel Group Study Comparing Efficacy and Safety of 5 mg/ml Ropivacaine and 5 mg/ml Bupivacaine for Spinal Anaesthesia in Patients Undergoing Unilateral Lower Limb Surgery |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anesthesia, Spinal |
| Intervention type | Drug |
| Interventions | Ropivacaine, Bupivacaine |
| Enrollment | 220 |
| Start date | Apr 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Jul 31, 2006 |
| Last update posted | Mar 26, 2009 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: